Actively Recruiting
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
Led by Sun Yat-sen University · Updated on 2026-05-11
50
Participants Needed
1
Research Sites
228 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The observational clinical study will recruit 50 recurrent and/or metastatic nasopharyngeal carcinoma (r/mNPC) patients, to investigate the prediction values of multi-omics technique for the efficacy of chemoradiotherapy combined with immunotherapy.
CONDITIONS
Official Title
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recurrent or metastatic nasopharyngeal carcinoma patients
- All genders, aged 18 to 70 years
- ECOG performance status score of 0 to 1
- Signed informed consent form
You will not qualify if you...
- Having or currently suffering from other malignant tumors
- Participating in other clinical trials
- Drug or alcohol addiction
- Lack of full legal capacity
- Mental disorder
- Pregnancy or breastfeeding
- Severe complications such as uncontrolled hypertension
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
J
Jingjing Miao, M.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here